scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1365-2141.1999.01673.X |
P698 | PubMed publication ID | 10520041 |
P2093 | author name string | H Suzuki | |
M Shibata | |||
I Tanaka | |||
A Yoshioka | |||
H Nakai | |||
M Shima | |||
J C Giddings | |||
K Nogami | |||
S Morichika | |||
E L Saenko | |||
D Scandella | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 196-203 | |
P577 | publication date | 1999-10-01 | |
P1433 | published in | British Journal of Haematology | Q4970200 |
P1476 | title | Identification of a factor VIII peptide, residues 2315-2330, which neutralizes human factor VIII C2 inhibitor alloantibodies: requirement of Cys2326 and Glu2327 for maximum effect | |
P478 | volume | 107 |
Q41966601 | A factor VIII-derived peptide enables von Willebrand factor (VWF)-binding of artificial platelet nanoconstructs without interfering with VWF-adhesion of natural platelets |
Q37382199 | B-cell and T-cell epitopes in anti-factor VIII immune responses |
Q37378510 | Characteristics, mechanisms of action, and epitope mapping of anti-factor VIII antibodies. |
Q36412125 | Characterization of factor VIII inhibitors |
Q30481770 | Covalent inactivation of factor VIII antibodies from hemophilia A patients by an electrophilic FVIII Analog |
Q45855091 | High throughput mutation screening of the factor VIII gene (F8C) in hemophilia A: 37 novel mutations and genotype-phenotype correlation |
Q36317966 | Highly conserved antigenic structure of the factor VIII C2 domain in some mammals. |
Q31056138 | Low molecular weight peptides restore the procoagulant activity of factor VIII in the presence of the potent inhibitor antibody ESH8. |
Q80273707 | Relationship between the binding sites for von Willebrand factor, phospholipid, and human factor VIII C2 inhibitor alloantibodies within the factor VIII C2 domain |
Search more.